Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |